AB052. ZEB1 promotes vasculogenic mimicry formation in prostate cancer is associated with epithelial-mesenchymal transition
Printed Abstracts

AB052. ZEB1 promotes vasculogenic mimicry formation in prostate cancer is associated with epithelial-mesenchymal transition

Hua Wang, Zongren Wang, Shaopeng Qiu

Department of Urology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China


Background: This study investigated the role of ZEB1 in vasculogenic mimicry (VM) formation and the interplay between VM and epithelial-mesenchymal transition (EMT).

Methods: Ninety-two prostate cancer tissue specimens were stained by CD34 and periodic acid Schiff. Then, we stained ZEB1 protein in the consecutive sections. Moreover, prostate cancer cells were subjected to ZEB1 knockdown using ZEB1 siRNA and then to 3D culture assay. EMT related maker was also evaluated.

Results: The data showed that the presence of VM and high ZEB1 expression were associated with higher Gleason score, TNM stage, and lymph node and distant metastases. ZEB1 knockdown reduced VM formation and the expression of EMT-related in prostate cancer cells.

Conclusions: In the current study was the first to reveal that ZEB1 played an important role in VM formation in prostate cancer ex vivo and in vitro. Mechanistically, this process may have a relationship with EMT.

Keywords: Prostate cancer; vasculogenic mimicry (VM); ZEB1, epithelial-mesenchymal transition (EMT)


doi: 10.21037/tau.2017.s052


Cite this abstract as: Wang H, Wang Z, Qiu S. ZEB1 promotes vasculogenic mimicry formation in prostate cancer is associated with epithelial-mesenchymal transition. Transl Androl Urol 2017;6(Suppl 3):AB052. doi: 10.21037/tau.2017.s052

Download Citation